Navigation Links
First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies
Date:6/24/2008

Multi-Disciplinary Oversight Panel Includes American Brachytherapy Society, American Society of Breast Surgeons and American College of Radiation

Oncology

SUNNYVALE, Calif., June 24 /PRNewswire/ -- Xoft, Inc. today announced the launch and of the EXIBT Study (Electronic Xoft Intersociety Brachytherapy Trial), a national Electronic Brachytherapy patient registry under oversight from three national physician societies, the American Brachytherapy Society (ABS), the American Society of Breast Surgeons (ASBrS), and the American College of Radiation Oncology (ACRO). The first patient was successfully enrolled and treated in the registry by Drs. Peter Beitsch of the Dallas Breast Center and Timothy Nichols of the Northpoint Cancer Center in Dallas, Texas.

With an enrollment goal of 400 patients, the objective of the multi-center study is to assess the long-term safety and efficacy of the Xoft Axxent(R) Electronic Brachytherapy System for the treatment of early stage breast cancer patients. The primary endpoint is the measurement and quantification of skin and subcutaneous toxicities through five year follow-up. An important additional primary endpoint includes a quality of life questionnaire based on patient experience with this new form of radiation therapy. Secondary endpoints assess local-regional breast failure and patient survival through five years as well as device performance.

"From earlier diagnosis to decreased morbidities and treatment times and ultimately, improved survival, we have made great strides in treating women with breast cancer. For many women, post lumpectomy radiation therapy can now be completed in one week with brachytherapy compared to the 6-7 weeks required for external beam therapy," said Peter Beitsch, MD, co-Principal Investigator of EXIBT and the surgeon for the first patient on the registry. Dr. Beitsch is director of the Dallas Breast Center and a Board Member of the American S
'/>"/>

SOURCE Xoft, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Sept. 18, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... focused on licensing, developing and commercializing innovative biopharmaceutical ... exercise of the underwriters, option to purchase 675,000 ... the company,s previously announced public offering of 4,500,000 ... are being offered by Aratana Therapeutics.  With the ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... Market Monitor : Global Chiral Separation Columns Market" ... chromatography is a technique involving two enantiomers of the ... consisting of a single enantiomer, thus possessing different elution ... such as cellulose. The chiral separation chromatography ...
(Date:9/18/2014)... , Sept. 18, 2014  Decision Resources ... the United States , 54 ... GlaxoSmithKline,s BRAF inhibitor Tafinlar for BRAF -mutation-positive ... who have prescribed GlaxoSmithKline,s MEK inhibitor Mekinist. Among ... percentage (42 percent and 43 percent, respectively) expects ...
Breaking Medicine Technology:Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 2Micro Market Monitor: Global Chiral Separation Columns Market 2At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients 2
... The award recognizes outstanding journalism demonstrating the ... discoveries and scientific,breakthroughs., WASHINGTON, June 19 ... announces the winners of the 7th Annual,Michael ... in honor of FBR,s,Chairman and 2008 Congressional ...
... Kendle (Nasdaq: KNDL ), a,leading global full-service ... its experts will present at the upcoming Drug,Information ... scheduled,for June 22-26, 2008, at the Boston Convention ... speak on key topics in the clinical,development industry, ...
Cached Medicine Technology:The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards 2Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 2Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 3
(Date:9/18/2014)... Kent, WA Chiropractor Danene Saggau and the ... that Dawn Kelly has agreed to become the new Office ... to Ms. Kelly expanding her role within the practice, noting ... key contributor. “ Dawn Kelly brings to the clinic ... that will allow me to focus on the patient ...
(Date:9/18/2014)... Alexandria, VA — The Public Health ... communities have joined the growing ranks of those reaping ... decisions bring the number of governmental public health departments ... non-profit organization that administers the national public health accreditation ... of the public by advancing the quality and performance ...
(Date:9/18/2014)... -- Older people become more physically vulnerable during bereavement, ... stress hormones during bereavement changes with age, British researchers ... are more likely to have weakened immune systems and ... weeks and months after loss, we can suffer from ... of white blood cell and as such are essential ...
(Date:9/18/2014)... September 18, 2014 It’s been just a ... newest, patent pending bunion splint to website visitors, but already ... wrote: "I was absolutely delighted. It is perfect and I ... am wearing them. THANK YOU FOR LISTENING!!!" Another user ... saying, "The hole used to slip to the end of ...
(Date:9/18/2014)... Alan Mozes HealthDay Reporter , ... to emergency room waiting times, patients seeking care at larger ... the clock than those seen at smaller or more rural ... our ability to provide timely emergency care varies dramatically across ... of the new research, Dr. Renee Hsia, an associate professor ...
Breaking Medicine News(10 mins):Health News:Lake Meridian Chiropractic of Kent, WA Announces that Dawn Kelly Has Been Promoted to the Position of Office Manager 2Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3
... Iran: Revolution and Reproduction has been selected as this year,s ... Year of the Islamic Republic of Iran. Edited by Mohammad ... the first to attempt to explain why the fertility rate ... end of the 20th century. The prize is awarded by ...
... million deaths from cancer in Europe in 2011 according to ... Annals of Oncology today (Wednesday 9 February) [1]. ... for the first time in Europe a new mathematical model ... death rates for both men and women when compared to ...
... Scientific American MIND to present an event just in time ... what makes romantic relationships succeed or fail. The ... 2011, 7:00 PM - 8:30 PM at The New York ... City. According to Columbia University psychiatrist and neuroscientist Amir ...
... by Boston University School of Public Health (BUSPH) researchers ... help smokers quit, producing six-month abstinence rates nearly double ... study published online ahead of print in the American ... of respondents reported having quit smoking six months after ...
... TUESDAY, Feb. 8 (HealthDay News) -- Babies who are exposed ... virus have lower levels of antibodies to diseases such as ... Researchers collected serum samples from 104 HIV-infected and uninfected South ... again from 93 of the infants at 16 weeks of ...
... , TUESDAY, Feb. 8 (HealthDay News) -- In pregnant women, ... significantly higher blood pressure, new research suggests. The study ... had a lead level higher than about 1 microgram per ... lower than the safety thresholds set by the U.S Centers ...
Cached Medicine News:Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 2Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 3Health News:Electronic cigarettes hold promise as aid to quitting 2Health News:Mom's HIV May Lower Baby's Immunity to Other Diseases 2Health News:Lead Exposure May Raise Blood Pressure in Pregnancy 2
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
... cover the range from 2ul to 5000ul. ... lock design prevents inadvertent volume change. Novel ... Whole pipette is autoclavable at 121C(250F). To ... Suitable for one-handed operation. Auto or ...
... offers improved ergonomics for today's exacting ... grippy finger rest and the large ... efficiency. Finnpipette Digitals also feature soft-touch ... (pat. pend.) and super blow-out for ...
... In the specialty areas ... or intensive care work, it ... in your practice. Alokas motorized ... Doppler and Tissue Harmonic Echo ...
Medicine Products: